Vyome Holdings acquires MIT spinout Oculo Health and launches a new business unit to develop an AI psychiatrist focused on treating systemic inflammation.
Read Moreclinical-stage healthcare holding company
Vyome and Embryyo Sign MoU to Develop AI-Enabled Medical Devices
Vyome and Embryyo sign MoU to jointly develop AI-enabled medical devices, aiming to transform healthcare innovation across the U.S.-India corridor.
Read More